Delivery Order SPE2DB22D6029-SPE2DB25FLVQW
Award Date 7/30/25
Potential Completion Date 8/20/25
Potential Value $8.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $8,123.96 to AmerisourceBergen Drug Corp for Ibrance 75 mg capsules (21-count unit) on July 22, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. Ibrance is a prescription oncology medication used in cancer treatment, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $8,123.96 to supply Ibrance 75 mg tablets (quantity 7) with a firm fixed price structure. This non-set-aside, competitively awarded contract is designated as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $8,122.48 to AmerisourceBergen Drug Corp for the supply of Ibrance 100 mg tablets (quantity of seven units). This firm fixed-price delivery order, issued on July 25, 2025, carries an ultimate completion date of August 15, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Ibrance (palbociclib) is a cyclin-dependent...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,122.48 on August 12, 2025, for the supply of Ibrance 100 mg tablets (7-unit package). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 3, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- This delivery order, awarded July 30, 2025, by the Defense Logistics Agency's Medical Supply Chain to AmerisourceBergen Drug Corp, provides for the supply of Ibrance 75 mg tablets in quantities of seven tablets per unit. The contract, valued at $64,987.24 with a firm fixed price structure, is scheduled for completion by August 20, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded a $8,118.08 firm fixed price delivery order to AmerisourceBergen Drug Corp for Ibrance 125 mg capsules (21-count) on July 21, 2025, with an ultimate completion date of August 11, 2025. The contract, which carries no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a competitively awarded procurement from the company's existing pharmaceutical supply agreement...
- The Defense Logistics Agency awarded a delivery order valued at $8,118.08 to AmerisourceBergen Drug Corp for 21 capsules of Ibrance 125 mg, a prescription oncology medication used in cancer treatment. Issued on July 29, 2025, with an ultimate completion date of August 19, 2025, this firm fixed-price delivery order represents a competitively awarded, non-set-aside procurement with no small business restrictions. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $8,118.08 to AmerisourceBergen Drug Corp for Ibrance 125 mg capsules (21-count) on August 13, 2025, with completion scheduled for September 4, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation to the pharmaceutical distributor's corporate office in Conshohocken, Pennsylvania. The award represents a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $8,118.08 delivery order to AmerisourceBergen Drug Corp for Ibrance 125 mg capsules (21-count packaging) on August 5, 2025, with completion scheduled for August 26, 2025. This firm fixed price contract represents a non-competitive set-aside and will be performed at the contractor's Conshohocken, Pennsylvania location. Ibrance is a specialty oncology medication used in cancer treatment, reflecting the federal government's ongoing need for critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Ibrance 125 mg tablets (7-count packages) with a ceiling value of $16,236.16. This competitive award, issued without set-aside designation, is structured as a firm fixed price delivery order with an ultimate completion date of September 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with performance to be...